This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN p70S6K:Preservative Free
catalog :
MCA3430Z
quantity :
0.1 mg
price :
547 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1E12
reactivity :
human
application :
western blot, immunocytochemistry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA3430Z
Description :
MOUSE ANTI HUMAN p70S6K:Preservative Free
Specificity :
p70S6K
TargetSpecies :
Human
Host :
Mouse
Format :
Preservative Free
Isotypes :
IgG2b
Applications :
WB,P*,IF
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,Immunofluorescence
Clone :
1E12
Quantity :
0.1 mg
QuantityValue :
0.1
QuantityType :
mg
GOAccessions :
GO:0045202,GO:0045931,GO:0043066,GO:0045948,GO:0000082,GO:0005515,GO:0005829,GO:0006915,GO:0030054,GO:0031929,GO:0019717,GO:0048015,GO:0008286,GO:0005737,GO:0005741,GO:0004672,GO:0005524,GO:0005634
GOTerms :
alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,apoptotic cell death,apoptotic program,apoptotic programmed cell death,GO:0008632,programmed cell death by apoptosis,signaling (initiator) caspase activity,type I programmed cell death,GO:0050222,protamine kinase activity,cell nucleus,outer mitochondrial membrane,daf-2 receptor signaling pathway,insulin receptor signalling pathway,inositol phospholipid-mediated signaling,phosphatidylinositol-mediated signalling,phosphoinositide-mediated signaling,phosphoinositide-mediated signalling,target of rapamycin signaling pathway,target of rapamycin signalling pathway,TOR signaling pathway,TOR signalling pathway,down regulation of apoptosis,downregulation of apoptosis,down-regulation of apoptosis,inhibition of apoptosis,synaptic junction,activation of progression through mitotic cell cycle,positive regulation of mitotic cell cycle progression,positive regulation of progression through mitotic cell cycle,stimulation of progression through mitotic cell cycle,up regulation of progression through mitotic cell cycle,upregulation of progression through mitotic cell cycle,up-regulation of progression through mitotic cell cycle,activation of translational initiation,stimulation of translational initiation,up regulation of translational initiation,upregulation of translational initiation,up-regulation of translational initiation
UniprotAccessions :
P23443
Gene :
RPS6KB1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6198
PublishedSynonyms :
RPS6KB1
EntityFormats :
Preservative Free
UNSPSC :
41116161
Concentration :
Ig concentration 0.5 mg/ml
ProductForm :
Purified IgG - liquid
PriceGBP :
391
PriceEUR :
547
PriceUSD :
547 USD
PriceCHF :
596.23
PriceSEK :
5749
PriceNOK :
5858
PriceDKK :
4081
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.